经鼻湿化快速充气通气交换(THRIVE)在儿童中的应用:一项随机对照试验
该随机对照试验纳入48名健康儿童,比较THRIVE与单纯托下颌在无呼吸期间的安全无呼吸时间。结果显示THRIVE组各年龄段无呼吸时间均显著长于对照组,经皮血氧饱和度维持在99.6%,但两组经皮CO2上升速率相似,提示THRIVE延长安全无呼吸时间但不改善CO2清除。
要点
- THRIVE可显著延长健康儿童无呼吸期间的安全时间。
- THRIVE期间经皮血氧饱和度平均维持在99.6%。
- THRIVE不改善CO2清除,两组CO2上升速率均为2.4 mm Hg min-1。
核心结论
- 经鼻湿化快速充气通气交换(THRIVE)可延长健康儿童的安全无呼吸时间,但对CO2清除无改善作用。
研究设计与样本
- 随机对照试验,纳入48名气道及心肺功能正常的健康儿童,按年龄段0-6、7-24个月、2-5、6-10岁分组,每组各24例接受THRIVE或对照(托下颌)干预。
主要发现
- 无呼吸时间对照组与THRIVE组分别为:0-6个月109.2(95%CI 28.8)s与192 s;7-24个月147.3(95%CI 18.9)s与237 s;2-5岁190.5(95%CI 15.3)s与320 s;6-10岁260.8(95%CI 37.5)s与430 s。
- THRIVE期间平均经皮血氧饱和度为99.6%(95%CI 0.2)。
- 经皮CO2上升速率对照组为2.4(95%CI 0.5)mm Hg min-1,THRIVE组为2.4(95%CI 0.4)mm Hg min-1。
临床怎么用
- 在健康儿童无呼吸期间可考虑使用THRIVE以延长安全无呼吸时间,但需注意其不能改善CO2清除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) was introduced to adult anaesthesia to improve the safety of airway management during apnoea before intubation. The objective of our study was to determine whether THRIVE safely prolongs apnoeic oxygenation in children. METHODS: This was a randomized controlled trial in 48 healthy children, with normal airways and cardiorespiratory function, in age groups 0-6 and 7-24 months, 2-5 and 6-10 yr old, presenting for elective surgery or imaging under general anaesthesia. All children were induced with sevoflurane, O2, and N2O, followed by muscle relaxation with rocuronium, and standardized preoxygenation with bag-and-mask ventilation. The control arm received jaw support during apnoea, whereas the THRIVE arm received jaw support during apnoea and age-specific flow rates. The primary outcome was to demonstrate that children allocated to THRIVE maintain transcutaneous haemoglobin saturation at least twice as long as the expected age-dependent apnoea time in the control group. RESULTS: Both study arms (each n=24) were similar in age and weight. The apnoea time was significantly shorter in the control arm: average 109.2 (95% CI 28.8) s in the control arm and 192 s in the THRIVE arm (0-6 months), 147.3 (95% CI 18.9) and 237 s (7-24 months), 190.5 (95% CI 15.3) and 320 s (2-5 yr), and 260.8 (95% CI 37.5) and 430 s (6-10 yr), respectively. Average transcutaneous haemoglobin saturation remained at 99.6% (95% CI 0.2) during THRIVE. Transcutaneous CO2 increased to a similar extent in both arms, with 2.4 (95% CI 0.5) mm Hg min-1 for the control arm and 2.4 (95% CI 0.4) mm Hg min-1 for the THRIVE arm. CONCLUSION: Transnasal humidified rapid-insufflation ventilatory exchange prolongs the safe apnoea time in healthy children but has no effect to improve CO2 clearance. CLINICAL TRIAL REGISTRATION: ACTRN12615001319561.
引用
- Humphreys S, Lee-Archer P, Reyne G, et al. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) in children: a randomized controlled trial. Br J Anaesth. 2017. PMID: 28100527. doi:10.1093/bja/aew401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。